The Patient-Centric Pharma Company: Evolution, Reboot, or Revolution?

This chapter focuses on the evolution of the priorities and processes of the life science industry driven by an increasing orientation on the patient. The author describes the megatrends which affect the scorecard of the life science industry and underscores the impact of the societal trends on R&D and on the management of innovation. The author next describes the combined role of societal expectations and of new players which drive new approaches from all stakeholders. The author concludes with the consequences in terms of governance and capabilities for the industry and offers some conclusions for a path to sustainable development for the life science industry.
​
For Read More →
http://onlinelibrary.wiley.com/doi/10.1002/9783527693405.ch14/summary